Latest Breaking News On - Bassem maximos - Page 1 : comparemela.com

New postpartum depression drugs are here Diagnosis, treatment hurdles still stand in the way

BioPharma

United statesLeague cityBassem maximosJudith josephBrii biosciencesKatherine wisnerNancy byattMichelle visserUniversity of north carolina school medicineUmass chan medical schoolAmerican college of obstetriciansPatient health questionnaireChildren national hospitalUs preventative services taskAmerican psychological associationLangone health

Parlor Doughnuts brings new craft donut shop to Nassau Bay

Parlor Doughnuts brings new craft donut shop to Nassau Bay
houstonchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from houstonchronicle.com Daily Mail and Mail on Sunday newspapers.

United statesNew providenceDarrick haydenJosh tudelaBassem maximosBaher maximosNassau bayParlor doughnutsBay area based

Evofem Presents Data Detailing Fewer Urinary Tract Infections in Women Using Phexxi in the Phase 3 AMPOWER Clinical Trial

/PRNewswire/ Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced that new data from the Phase 3 AMPOWER clinical trial of Phexxi® (lactic acid, citric.

San diegoUnited statesAmy raskopfEvofem bioscienceJack hirschfieldSaundra pelletierEvofem biosciencesBassem maximosAmerican college of obstetriciansSecurities exchangeEvofem biosciences incPrnewswire evofem biosciences incOn study urinary tract infection comparedAnnual meetingAmerican collegeScientific meeting

Evofem Biosciences Announces Presentation of Two New Phexxi Data Sets at the 2021 American College of Obstetricians and Gynecologists Annual Meeting

Evofem Biosciences Announces Presentation of Two New Phexxi Data Sets at the 2021 American College of Obstetricians and Gynecologists Annual Meeting News provided by Share this article Share this article SAN DIEGO, April 28, 2021 /PRNewswire/ Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that two new data sets from its Phase 3 AMPOWER trial evaluating ® (lactic acid, citric acid, potassium bitartrate) will be presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM). The meeting will be conducted virtually from April 30 - May 2, 2021. These new data sets provide clinical insights into how women used Phexxi in the AMPOWER clinical trial as well as their feelings about pregnancy, which are both important factors for clinicians to consider when counseling and prescribing Phexxi, said Brandi Howard, PhD, Head of Medical Affairs at Evofem Biosciences.

United statesClint dartPatty casonDavidj portmanDavidl eisenbergEvofem biosciencesEllen thomasBrandon howardEvofem bioscienceKelly culwellBrandi howardBassem maximosBiosciences incHead of medical affairs at evofem biosciencesAmerican college of obstetriciansSecurities exchange